Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease

27Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.

Cite

CITATION STYLE

APA

Beresford, M. W., Primhak, R., Subhedar, N. V., & Shaw, N. J. (2002). Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease. Archives of Disease in Childhood: Fetal and Neonatal Edition, 87(1). https://doi.org/10.1136/fn.87.1.f62

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free